New research maps the global burden of male cancers from 1990 to 2040, showing how aging, lifestyle, and healthcare access ...

There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for patients with stage 3 or 4 kidney cancer, who face high recurrence risk.

I saw this as something that I thought would change me,” said Clark Gamblin, a cancer surgeon in Milwaukee. “And change me ...

In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.